SCHEMBL17777232

SCHEMBL17777232

C=CC1CC(C(=O)OC)C[C@@H](O)C1OC1O[C@@H](C)C(OCCCC)C(OCCCC)[C@@H]1OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19491796 1.00
SCHEMBL17151668 1.00
SCHEMBL17777234 1.00
SCHEMBL17777224 0.91 PPP5C (0.33)
SCHEMBL14823288 0.88 GJB2 (0.31)
SCHEMBL12246441 0.88 GJB2 (0.31)
SCHEMBL14823287 0.88 GJB2 (0.31)
SCHEMBL18938432 0.87 GJB2 (0.30)
SCHEMBL18938431 0.87 GJB2 (0.30)
SCHEMBL17148773 0.83 BCHE (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9796745-B2 E-selectin antagonist compounds, compositions, and methods of use GLYCOMIMETICS, INC. (US) 2017-10-24 US disclosed
US-20170296566-A9 METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITIS GLYCOMIMETICS, INC. (US) 2017-10-19 US disclosed
US-20160243145-A1 METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITIS GLYCOMIMETICS, INC. (US) 2016-08-25 US disclosed
US-20160145290-A1 E-SELECTIN ANTAGONIST COMPOUNDS, COMPOSITIONS, AND METHODS OF USE GLYCOMIMETICS, INC. 2016-05-26 US disclosed